Poradosu Enrique 13D and 13G filings for Nuvectis Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-31 7:34 pm Purchase | 2023-12-31 | 13G | Nuvectis Pharma, Inc. NVCT | Poradosu Enrique | 1,503,819 8.700% | 285,500 (+23.43%) | Filing |
| 2023-02-13 5:15 pm Purchase | 2022-12-31 | 13G | Nuvectis Pharma, Inc. NVCT | Poradosu Enrique | 1,218,319 8.300% | 1,218,319 (New Position) | Filing |